Overview

Stem Cell Therapy for Chronic Kidney Disease

Status:
Recruiting

Trial end date:
2027-05-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the safety and tolerability of allogeneic mesenchymal stem / stromal cell therapy in individuals with chronic kidney disease.

Phase:

Phase 1

Details

Lead Sponsor:

LaTonya J. Hickson